Results

Total Results: 2,065 records

Showing results for "years".

2061. Peripheral-Artery-Disease-Treatment Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
      January 31, 2013 - among younger patients, such that estimates of asymptomatic or symptomatic PAD among patients 45 to 64 years … , all trials did show an increase in maximum walking distance in the exercise arm at 6 months to 2 years … supervised exercise and medical therapy alone with respect to maximum walking distance and ABI at 2 years … of age, or some patients are <18 years of age, but results are not broken down by age Interventions … Mortality over a period of 10 years in patients with peripheral arterial disease.

2062. Disposition of Comments for Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
      December 16, 2014 - Yet median follow-up for SPCG-4 was 12.8 years in the most recent analysis published in 2011. … If so, then shouldn’t the SPCG-4 risk of bias be “medium” at 15 years as well? … are correct - fewer than 85 percent of the enrolled patients provided data at the followup of 15 years … throughout the text as well as the demonstrated benefit at 15 years. … Agree that current RCTs were initiated many years ago and there has been evolution in diagnosis and

2063. The Role of Immunotherapy in the Treatment of Asthma--Evidence Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-196-evidence-summary-immunotherapy-asthma.pdf
      March 01, 2018 - e Effective Health Care Program Archived: This report is greater than 3 years old. … Direct Precise Undetected SLIT does not increase the risk of death Moderate 7 children 5 to 11 years … age in studies, or, if a broader age is studied, reporting separately findings on children 5 to 11 years … Efficacy and safety of sublingual immunotherapy in children aged 3-13 years with allergic rhinitis.

2064. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/ischemic-stroke-treatment_executive.pdf
      January 01, 2011 - Studies typically enrolled patients older than 18 years of age, with baseline NIHSS scores ≥8 (or ≥10 … The range for mean/median age was 42 to 68 years and studies enrolled 20 to 57 percent females. … However, some case series and reports included both pediatric patients, those older than 80 years of … However, studies of emerging technologies over the past 20 years have suggested that inadequate physician

2065. Autism-Update Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_executive.pdf
      August 01, 2014 - adaptive behavior when the intervention was delivered over substantial intervals of time (i.e., 1–2 years … Children ages 0-2 years considered to be at risk for ASD diagnosis 7 Children ages 0-12 years … is not yet clear, and many studies did not follow children beyond late preschool or early school years … Most studies of social skills interventions targeted elementary school–aged children (6–13 years old … ); and many different outcome measurements over different periods of time (weeks to years).